WeightWatchers CEO Sima Sistani talks TikTok, Telehealth Deal on GLP-1/Ozempic and Why She Took the Job
Media Type |
audio
Categories Via RSS |
News
News Commentary
Society & Culture
Publication Date |
Apr 06, 2023
Episode Duration |
00:54:07
WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: why is a company built on personal accountability facilitating medical interventions? We ask our guest, WeightWatchers CEO Sima Sistani. Before and after the interview, Nayeema and Kara discuss their own experiences with diet fads and whether drugs like Wegovy and Ozempic will help America deal with the obesity epidemic or simply avoid tackling underlying issues like food supply, corporate greed and light regulation. Questions? Comments? Email us at on@voxmedia.com or find us on Twitter @karaswisher and @nayeema  Learn more about your ad choices. Visit podcastchoices.com/adchoices

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review